Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...

Aspirin has been shown to effectively reduce recurrence rates and improve disease-free survival,” said Anna Martling, MD, PhD.

Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.

After endoscopic documentation of ulcer healing, patients received either clopidogrel (75 mg daily) plus placebo or aspirin (80 mg daily) plus esomeprazole (20 mg twice daily). Patients who tested ...

or 80-mg Pravachol tablets. The recommended daily dose is 40 mg Pravachol with either 81 mg or 325 mg buffered aspirin. The daily dose of Pravachol is then titrated to achieve desired cholesterol ...

Adjuvant treatment with 160 mg aspirin daily for three years cuts recurrence rates in patients with colorectal cancer with ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new stu ...

Nearly one in three Americans over the age of 60 — roughly 19 million people — take aspirin daily, according to a 2021 study in Annals of Internal Medicine. Should you be among that group?